SBL
Sargent Bickham Lagudis’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $9.18M | Sell |
179,151
-216
| -0.1% | -$11.1K | 0.75% | 30 |
|
|
2022
Q3 | $7.85M | Sell |
179,367
-815
| -0.5% | -$35.7K | 0.7% | 34 |
|
|
2022
Q2 | $9.45M | Sell |
180,182
-140,869
| -44% | -$7.39M | 0.82% | 29 |
|
|
2022
Q1 | $16.6M | Buy |
321,051
+1,232
| +0.4% | +$63.8K | 1.29% | 18 |
|
|
2021
Q4 | $18.9M | Sell |
319,819
-10,101
| -3% | -$596K | 1.43% | 14 |
|
|
2021
Q3 | $14.2M | Buy |
329,920
+4,609
| +1% | +$198K | 1.16% | 18 |
|
|
2021
Q2 | $12.7M | Sell |
325,311
-2,388
| -0.7% | -$93.5K | 1.04% | 20 |
|
|
2021
Q1 | $11.9M | Buy |
327,699
+1,734
| +0.5% | +$62.8K | 1.05% | 18 |
|
|
2020
Q4 | $12M | Buy |
325,965
+11,140
| +4% | +$410K | 1.11% | 17 |
|
|
2020
Q3 | $11.6M | Buy |
314,825
+3,576
| +1% | +$131K | 1.16% | 16 |
|
|
2020
Q2 | $10.2M | Buy |
311,249
+25
| +0% | +$818 | 1.09% | 18 |
|
|
2020
Q1 | $10.2M | Buy |
311,224
+292,401
| +1,553% | +$9.54M | 1.31% | 17 |
|
|
2019
Q4 | $738K | Buy |
18,823
+1,632
| +9% | +$64K | 0.08% | 125 |
|
|
2019
Q3 | $618K | Buy |
17,191
+748
| +5% | +$26.9K | 0.07% | 129 |
|
|
2019
Q2 | $712K | Sell |
16,443
-377
| -2% | -$16.3K | 0.08% | 124 |
|
|
2019
Q1 | $714K | Sell |
16,820
-509
| -3% | -$21.6K | 0.08% | 131 |
|
|
2018
Q4 | $756K | Buy |
17,329
+920
| +6% | +$40.1K | 0.1% | 123 |
|
|
2018
Q3 | $723K | Buy |
16,409
+436
| +3% | +$19.2K | 0.09% | 129 |
|
|
2018
Q2 | $579K | Sell |
15,973
-1,114
| -7% | -$40.4K | 0.07% | 135 |
|
|
2018
Q1 | $606K | Sell |
17,087
-1,535
| -8% | -$54.4K | 0.08% | 132 |
|
|
2017
Q4 | $674K | Sell |
18,622
-3,109
| -14% | -$113K | 0.08% | 133 |
|
|
2017
Q3 | $776K | Sell |
21,731
-422
| -2% | -$15.1K | 0.1% | 129 |
|
|
2017
Q2 | $744K | Buy |
22,153
+685
| +3% | +$23K | 0.09% | 130 |
|
|
2017
Q1 | $734K | Buy |
21,468
+1,298
| +6% | +$44.4K | 0.1% | 131 |
|
|
2016
Q4 | $655K | Sell |
20,170
-1,055
| -5% | -$34.3K | 0.1% | 123 |
|
|
2016
Q3 | $719 | Buy |
21,225
+2,518
| +13% | +$85 | 0.11% | 122 |
|
|
2016
Q2 | $659K | Buy |
18,707
+4,201
| +29% | +$148K | 0.1% | 127 |
|
|
2016
Q1 | $430K | Buy |
+14,506
| New | +$430K | 0.07% | 143 |
|